July 2019 - St. Jude Progress Blog - St. Jude Children’s Research Hospital

What I’m telling my patients and families about sunscreen

Posted by Teresa Wright, MD | Jul 31, 2019 | Clinical Care | 0

A recent study finds some of the active chemicals in sunscreen are absorbed into the bloodstream. A pediatric dermatologist lets parents know what the options are.

New chemotherapies change the paradigm of cancer treatment

Posted by Arijit Basu | Jul 30, 2019 | Clinical Care | 0

New treatments have led to new thinking and new approaches to pediatric cancer – and sometimes, a cure isn’t the goal.

Lando: Star Wars smuggler or possible ally against Alzheimer’s disease?

Posted by Mary Powers | Jul 25, 2019 | Research | 0

Naming a new scientific discovery sometimes takes deep thought and engaged conversation. This lab relied on “the force” to come up with a perfect name.

SJELIOT clinical trial explores a new approach for recurring and unresponsive medulloblastoma tumors

Posted by Gary Bridgman | Jul 23, 2019 | Clinical Care | 0

A new St. Jude Children’s Research Hospital clinical trial, SJELIOT, is evaluating an adult cancer drug that shows potential for improved treatment of high-risk pediatric brain tumors. This phase I investigation is evaluating the combination of a kinase inhibitor (prexasertib) with established anti-cancer agents in children and adolescents who have recurrent or refractory (unresponsive) medulloblastoma, the most common malignant brain tumor in childhood. Leading SJELIOT is neuro-oncologist Giles Robinson, MD, who is also running the SJDAWN clinical trial. “We are very excited to launch this clinical trial,” Robinson said, “since it translates years of very promising laboratory work by...